PIONEERING VIRTUAL BIOPSIES
Live cellular imaging without incisions
Where live imaging and deep data meet.
Enspectra Health is pioneering a new field of virtual biopsies to transform the way physicians evaluate a broad spectrum of skin conditions.
Our novel technology combines reflectance confocal and multiphoton laser scanning microscopy to generate real-time, multispectral images spanning wavelengths not seen with the naked eye. The unique integration of these technologies produces images with increased depth, greater cellular detail, and more distinctive color contrast.
Our platform technology delivers pulsed near-infrared light through the skin’s surface, providing high-resolution images at the cellular level, without the need for an incision. The technology allows for an instantaneous evaluation of rich, digital pathology images of various skin tissues, potentially enabling earlier and less costly interventions.
Enspectra Health is developing technology targeted at dermatologists to aid in the evaluation of a variety of skin conditions.
Leveraging our novel platform technology, high-resolution, cellular images of the skin are produced noninvasively.
By arming clinicians with rich skin tissue images, we hope to aid in more informed decision making, with the ultimate goal of earlier disease diagnosis and interventions.
CAUTION: The Enspectra Health device is limited by United States law to investigational use and is not available for sale.
"Our mission is to develop and deploy technologies focused on earlier disease detection, leveraging revolutionary imaging and machine learning, in order to transform patient care."
- Gabriel Sanchez, CEO Enspectra Health
Advancing Intelligent Imaging
CoFounder & CEO
Leveraging his extensive experience innovating in the fields of optics and electromechanical devices, Gabriel serves as the visionary for Enspectra Health. Working with a team of experts, Gabriel is leading the rapid advancement and development of Enspectra's multiphoton imaging device to evaluate a broad spectrum of skin conditions.
President & COO
Bill has over 20 years of experience in medical device executive management, operations, manufacturing, supply chain, and infrastructure. He has supported product launches and scale up activities at several device startups, leading to acquisitions by companies such as Hologic, Medtronic and Stryker Corporation.
GRACE KAO LI
VP of Quality and Regulatory
Grace is a seasoned quality and regulatory leader with over 20 years of experience building high-functioning teams and compliance operations in the medical device and digital health industries. She has driven complex program strategies in exceptionally dynamic environments, ranging from startups to Fortune 100 companies.
VP of Commercial Strategy
Shelley brings over 20 years of experience commercializing early-stage medical and digital health technologies. She is a proven leader with significant industry expertise in marketing, business development, strategic partnerships, and leading cross-functional teams to drive growth.
Mark is a professor of biology and applied physics at Stanford University who has pioneered microendoscopy for in vivo imaging. An expert in the custom design of optical instrumentation and multiphoton imaging techniques, his research at Stanford has spawned multiple scientific breakthroughs.